Search - tctmd.com

Displaying 981 - 1000 of 1859

Sort: Relevancy | Date

News Conference News TCT 2016

CMR Subanalysis of EXPLORE May Help Pinpoint Which CTO Regions Benefit From PCI

Yael L. Maxwell

November 01, 2016

Presentation TCT 2016

Strategy Trials: ISCHEMIA/EXCEL/FREEDOM: Strengths and Weaknesses

Presenter: Stuart J. Pocock, Jan G. P. Tijssen, David J. Cohen

November 01, 2016

Presentation TCT 2016

Critical Limb Ischemia: How to Develop a Comprehensive State-of-the-art Critical Limb Center

Presenter: George L Adams, John F Angle, Raghu Kolluri

October 31, 2016

Presentation TCT 2016

Debate: Should Most Patients With Anginal Chest Pain Undergo Angiography ± FFR? Yes For Definitive Diagnosis, and To Find and Treat Ischemia!

Presenter: Justin E. Davies, Ran Kornowski, Colin Berry

October 31, 2016

News Conference News TCT 2016

New BRS Studies Show Promise for Second-Generation Devices With Thinner Struts

Yael L. Maxwell

October 31, 2016

News Conference News TCT 2016

Cancer Patients Face Increased Risk of Acute MI, More PCI Complications, Higher Mortality, and Soaring Costs

Michael H. Wilson

October 31, 2016

Presentation TCT 2016

DEBATE: Predicting Thrombotic Events in Patients With STEMI and Multivessel Disease: The Degree of Stenosis/Ischemia Is Most Important!

Presenter: Ran Kornowski, Michel R. Le May, Anthony H. Gershlick

October 31, 2016

Presentation TCT 2016

TCT 18: Validation of Wound, Ischemia, Foot Ischemia (WIFI) classification System in Japanese Patients After Endovascular Treatment for Critical Limb Ischemia (CLI).

Presenter: Sriram S. Iyer, Craig M. Walker, Takahiro Tokuda

October 31, 2016

News Industry News

Trial Results Suggest That Drug-Eluting Stents Are Acceptable Alternative To Open Heart Surgery For Select Patients With Left Main Coronary Artery Disease

October 31, 2016

News Conference News TCT 2016

BIONICS: Ridaforolimus-Eluting Stent Noninferior to Zotarolimus Stent at 1 Year

TCT Daily Staff

October 30, 2016

Presentation TCT 2016

Rationale for and Design of ISCHEMIA: What I Expect the Findings to Be But What Wont Surprise Me!

Presenter: Jorge Gaspar, Bernard J. Gersh

October 30, 2016

Presentation TCT 2016

LIVE-IN-A-BOX CASE DEMONSTRATION: Mesentric Artery Intervention (Fibromuscular Dysplasia)

Presenter: Gary M. Ansel, Michael R. Jaff, D. Christopher Metzger

October 30, 2016

Presentation TCT 2016

Management of Visceral Artery Aneurysms: When to Intervene and How to Do It

Presenter: Gary M. Ansel, Michael R. Jaff, Constantino S. Pena

October 30, 2016

Presentation TCT 2016

Great Debate 1: The Optimal Management of Chronic Mesenteric Ischemia Is Catheter-based Intervention!

Presenter: Gary M. Ansel, Michael R. Jaff, Herbert D. Aronow

October 30, 2016

$TCT 1080: First-in-Man Prolonged Pressure-Controlled Intermittent Coronary Sinus Occlusion to Treat Refractory Left Ventricular Dysfunction and Ischemia$

Presentation TCT 2016

TCT 1080: First-in-Man Prolonged Pressure-Controlled Intermittent Coronary Sinus Occlusion to Treat Refractory Left Ventricular Dysfunction and Ischemia

Presenter: Tayo A. Addo, Jose de Ribamar Costa Jr, Francesco Giannini

October 30, 2016

Presentation TCT 2016

LIVE-IN-A-BOX CASE DEMONSTRATION: Renal Artery Intervention (Fibromuscular Dysplasia)

Presenter: Gary M. Ansel, Michael R. Jaff, D. Christopher Metzger

October 30, 2016

Presentation TCT 2016

Treatment of Renal Artery Fibromuscalar Dysplasia: Indications, Techniques, and Outcomes

Presenter: Gary M. Ansel, Michael R. Jaff, Mehdi H. Shishehbor

October 30, 2016

Presentation TCT 2016

Renal Artery Fibromuscular Dysplasia: Natural History and Treatment

Presenter: Gary M. Ansel, Michael R. Jaff

October 30, 2016

Presentation TCT 2016

Atheroscleotic Renal Artery Intervention: What Are the Remaining Indications?

Presenter: Gary M. Ansel, Michael R. Jaff, Sahil A. Parikh

October 30, 2016

News Industry News

Study Finds Ridaforolimus-Eluting Stent is Non-Inferior to Zotarolimus-Eluting Stent Based On One-Year Clinical Outcomes

October 30, 2016

Advertisement

CMR Subanalysis of EXPLORE May Help Pinpoint Which CTO Regions Benefit From PCI

Strategy Trials: ISCHEMIA/EXCEL/FREEDOM: Strengths and Weaknesses

Critical Limb Ischemia: How to Develop a Comprehensive State-of-the-art Critical Limb Center

Debate: Should Most Patients With Anginal Chest Pain Undergo Angiography ± FFR? Yes For Definitive Diagnosis, and To Find and Treat Ischemia!

New BRS Studies Show Promise for Second-Generation Devices With Thinner Struts

Cancer Patients Face Increased Risk of Acute MI, More PCI Complications, Higher Mortality, and Soaring Costs

DEBATE: Predicting Thrombotic Events in Patients With STEMI and Multivessel Disease: The Degree of Stenosis/Ischemia Is Most Important!

TCT 18: Validation of Wound, Ischemia, Foot Ischemia (WIFI) classification System in Japanese Patients After Endovascular Treatment for Critical Limb Ischemia (CLI).

Trial Results Suggest That Drug-Eluting Stents Are Acceptable Alternative To Open Heart Surgery For Select Patients With Left Main Coronary Artery Disease

BIONICS: Ridaforolimus-Eluting Stent Noninferior to Zotarolimus Stent at 1 Year

Rationale for and Design of ISCHEMIA: What I Expect the Findings to Be But What Wont Surprise Me!

LIVE-IN-A-BOX CASE DEMONSTRATION: Mesentric Artery Intervention (Fibromuscular Dysplasia)

Management of Visceral Artery Aneurysms: When to Intervene and How to Do It

Great Debate 1: The Optimal Management of Chronic Mesenteric Ischemia Is Catheter-based Intervention!

TCT 1080: First-in-Man Prolonged Pressure-Controlled Intermittent Coronary Sinus Occlusion to Treat Refractory Left Ventricular Dysfunction and Ischemia

LIVE-IN-A-BOX CASE DEMONSTRATION: Renal Artery Intervention (Fibromuscular Dysplasia)

Treatment of Renal Artery Fibromuscalar Dysplasia: Indications, Techniques, and Outcomes

Renal Artery Fibromuscular Dysplasia: Natural History and Treatment

Atheroscleotic Renal Artery Intervention: What Are the Remaining Indications?

Study Finds Ridaforolimus-Eluting Stent is Non-Inferior to Zotarolimus-Eluting Stent Based On One-Year Clinical Outcomes

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content